UBS Group’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $15.5K | Buy |
7,988
+7,985
| +266,167% | +$15.5K | ﹤0.01% | 7293 |
|
2025
Q1 | $8 | Sell |
3
-4,364
| -100% | -$11.6K | ﹤0.01% | 8810 |
|
2024
Q4 | $27.1K | Buy |
4,367
+4,364
| +145,467% | +$27.1K | ﹤0.01% | 6453 |
|
2024
Q3 | $26 | Sell |
3
-5,692
| -100% | -$49.3K | ﹤0.01% | 8072 |
|
2024
Q2 | $52.8K | Buy |
5,695
+3,671
| +181% | +$34.1K | ﹤0.01% | 5506 |
|
2024
Q1 | $26.8K | Buy |
2,024
+2,020
| +50,500% | +$26.8K | ﹤0.01% | 5615 |
|
2023
Q4 | $152 | Buy |
4
+1
| +33% | +$38 | ﹤0.01% | 7647 |
|
2023
Q3 | $36 | Sell |
3
-20
| -87% | -$240 | ﹤0.01% | 7906 |
|
2023
Q2 | $689 | Sell |
23
-46
| -67% | -$1.38K | ﹤0.01% | 7046 |
|
2023
Q1 | $7.08K | Buy |
69
+66
| +2,200% | +$6.77K | ﹤0.01% | 6753 |
|
2022
Q4 | $405 | Sell |
3
-4
| -57% | -$540 | ﹤0.01% | 9002 |
|
2022
Q3 | $3K | Sell |
7
-12
| -63% | -$5.14K | ﹤0.01% | 8462 |
|
2022
Q2 | $17K | Buy |
19
+2
| +12% | +$1.79K | ﹤0.01% | 6072 |
|
2022
Q1 | $44K | Sell |
17
-224
| -93% | -$580K | ﹤0.01% | 5602 |
|
2021
Q4 | $622K | Buy |
241
+140
| +139% | +$361K | ﹤0.01% | 3819 |
|
2021
Q3 | $462K | Buy |
101
+7
| +7% | +$32K | ﹤0.01% | 3785 |
|
2021
Q2 | $645K | Buy |
94
+55
| +141% | +$377K | ﹤0.01% | 3572 |
|
2021
Q1 | $286K | Sell |
39
-11
| -22% | -$80.7K | ﹤0.01% | 4278 |
|
2020
Q4 | $401K | Buy |
50
+45
| +900% | +$361K | ﹤0.01% | 3841 |
|
2020
Q3 | $55K | Buy |
5
+3
| +150% | +$33K | ﹤0.01% | 4735 |
|
2020
Q2 | $16K | Hold |
2
| – | – | ﹤0.01% | 5851 |
|
2020
Q1 | $11K | Hold |
2
| – | – | ﹤0.01% | 5965 |
|
2019
Q4 | $15K | Hold |
2
| – | – | ﹤0.01% | 5990 |
|
2019
Q3 | $17K | Sell |
2
-1
| -33% | -$8.5K | ﹤0.01% | 5869 |
|
2019
Q2 | $23K | Sell |
3
-2
| -40% | -$15.3K | ﹤0.01% | 5647 |
|
2019
Q1 | $41K | Buy |
5
+3
| +150% | +$24.6K | ﹤0.01% | 4889 |
|
2018
Q4 | $13K | Sell |
2
-5
| -71% | -$32.5K | ﹤0.01% | 6175 |
|
2018
Q3 | $62K | Buy |
7
+4
| +133% | +$35.4K | ﹤0.01% | 5113 |
|
2018
Q2 | $26K | Hold |
3
| – | – | ﹤0.01% | 5593 |
|
2018
Q1 | $14K | Buy |
3
+1
| +50% | +$4.67K | ﹤0.01% | 5781 |
|
2017
Q4 | $10K | Hold |
2
| – | – | ﹤0.01% | 6058 |
|
2017
Q3 | $22K | Hold |
2
| – | – | ﹤0.01% | 5479 |
|
2017
Q2 | $19K | Sell |
2
-2
| -50% | -$19K | ﹤0.01% | 5403 |
|
2017
Q1 | $40K | Buy |
4
+2
| +100% | +$20K | ﹤0.01% | 4785 |
|
2016
Q4 | $21K | Hold |
2
| – | – | ﹤0.01% | 5544 |
|
2016
Q3 | $28K | Hold |
2
| – | – | ﹤0.01% | 5127 |
|
2016
Q2 | $22K | Hold |
2
| – | – | ﹤0.01% | 5345 |
|
2016
Q1 | $25K | Hold |
2
| – | – | ﹤0.01% | 5220 |
|
2015
Q4 | $26K | Hold |
2
| – | – | ﹤0.01% | 5324 |
|
2015
Q3 | $19K | Hold |
2
| – | – | ﹤0.01% | 5487 |
|
2015
Q2 | $40K | Buy |
2
+1
| +100% | +$20K | ﹤0.01% | 4932 |
|
2015
Q1 | $11K | Buy |
+1
| New | +$11K | ﹤0.01% | 5806 |
|
2014
Q4 | – | Hold |
0
| – | – | – | 6350 |
|